Given that PPARγ activation evidently modulates lipid metabolism in lung cancer and generally known for inhibiting cancer cell proliferation, we wondered how the biochemical feature of the nuclear receptor would be mechanistically involved in the tumor suppressive function. Here, PPARG is linked to neoplasm.